This article was originally published in The Rose Sheet
FDA pushes back deadlines for compliance with its final rule for sunscreen labeling and effectiveness testing, giving manufacturers an additional six months for products with annual sales of at least $25,000. More news in brief.
You may also be interested in...
“The Rose Sheet” offers an overview of the year in cosmetics, analyzing 2012’s biggest news and the publication’s most-read stories. Highlights include a proposal in Obama’s 2013 budget request to institute cosmetics user fees, the rash of late-year warning letters and regulatory developments in California.
Dermatologists discuss the benefits and science of sunscreen formulas, emphasize daily use and address sunscreen truths and myths in the first episode of the Personal Care Products Council’s “Skin Smart” video series.
Merck agrees to pay a maximum of $10 million to consumers to settle class-action litigation. Firm’s compliance with sunscreen labeling and claims requirements that will become law in December under an FDA final rule satisfies plaintiffs, who took issue with past Coppertone claims that allegedly overstated products’ sun-protective benefits. The settlement in federal court resolves separate litigation against Coppertone filed in California state court.